Ivabradine tablets are a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: To reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction.
From the U.S. FDA-approved label for Ivabradine. Full label: DailyMed.
Ivabradine tablets are a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: To reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction. 1.1 Heart Failure in Adult Patients Ivabradine tablets are indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤ 35%, who are in sinus rhythm with resting heart rate ≥ 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use.
From the U.S. FDA-approved label for Ivabradine. Full label: DailyMed.
Adult patients Starting dose is 2.5 (vulnerable adults) or 5 mg twice daily with food. After 2 weeks of treatment, adjust dose based on heart rate. The maximum dose is 7.5 mg twice daily.
Directions from the U.S. FDA-approved label for Ivabradine — your doctor or pharmacist may advise differently.
Ivabradine is contraindicated in patients with: Acute decompensated heart failure, Clinically significant hypotension, Sick sinus syndrome, sinoatrial block or 3 rd degree AV block, unless a functioning demand pacemaker is present, Clinically significant bradycardia, Severe hepatic impairment, Pacemaker dependence (heart rate maintained exclusively by the pacemaker), Concomitant use of strong cytochrome P450 3A4 (CYP3A4) inhibitors, Acute decompensated heart failure, Clinically significant hypotension, Sick sinus syndrome…
Excerpt from the U.S. FDA-approved label for Ivabradine. Talk to a pharmacist or doctor before use.
Fetal toxicity: Females should use effective contraception., Monitor patients for atrial fibrillation., Monitor heart rate decreases and bradycardia symptoms during treatment., Not recommended in patients with 2 nd degree AV block. 5.1 Fetal Toxicity Ivabradine may cause fetal toxicity when administered to a pregnant woman based on findings in animal studies. Embryo-fetal toxicity and cardiac teratogenic effects were observed in fetuses of pregnant rats treated during organogenesis at exposures 1 to 3 times the human exposures (AUC 0-24hr ) at the maximum recommended human dose (MRHD).
Warnings and precautions excerpt from the U.S. FDA-approved label for Ivabradine — not a complete list. Talk to a pharmacist or doctor before use.
Clinically significant adverse reactions that appear in other sections of the labeling include: Atrial Fibrillation, Bradycardia and Conduction Disturbances Most common adverse reactions occurring in ≥ 1% of patients are bradycardia, hypertension, atrial fibrillation and luminous phenomena (phosphenes).
Excerpt from the U.S. FDA-approved label for Ivabradine — not a complete list. Talk to a pharmacist or doctor about side effects.
3 brands · 2 makers in the NepalDoc catalog — see the full Ivabradine guide →
Storage Store at 25°C (77°F);
Storage information from the U.S. FDA-approved label for Ivabradine.
What is Ivadrad?
Ivadrad 5mg Tablet is a Ivabradine medicine made by Lupin Ltd. It comes as 5mg Tablet.
What is the generic name of Ivadrad?
The generic name of Ivadrad is Ivabradine.
Which brands of Ivabradine are available in Nepal?
3 brands of Ivabradine are listed in the NepalDoc catalog, from 2 makers — including Inapure 5mg Tablet, Ivabrad Tablet.
What are the side effects of Ivabradine?
Clinically significant adverse reactions that appear in other sections of the labeling include: Atrial Fibrillation, Bradycardia and Conduction Disturbances Most common adverse reactions occurring in ≥ 1% of patients are bradycardia, hypertension, atrial fibrillation and luminous phenomena (phosphenes).
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.